Chen SH, Xie C. User-friendly prognostic model for rectal neuroendocrine tumours: In the era of precision management. World J Gastroenterol 2024; 30(45): 4850-4854 [DOI: 10.3748/wjg.v30.i45.4850]
Corresponding Author of This Article
Chuan Xie, MD, Chief Doctor, Teacher, Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Nanchang 330006, Jiangxi Province, China. xcsghhz@ncu.edu.cn
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 7, 2024; 30(45): 4850-4854 Published online Dec 7, 2024. doi: 10.3748/wjg.v30.i45.4850
User-friendly prognostic model for rectal neuroendocrine tumours: In the era of precision management
Si-Hai Chen, Chuan Xie
Si-Hai Chen, Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi Province, China
Chuan Xie, Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China
Author contributions: Chen SH wrote the manuscript; Xie C revised the manuscript.
Supported by the National Natural Science Foundation of China, No. 82100599 and No. 81960112; the Jiangxi Provincial Department of Science and Technology, No. 20242BAB26122; the Science and Technology Plan of Jiangxi Provincial Administration of Traditional Chinese Medicine, No. 2023Z021; and the Project of Jiangxi Provincial Academic and Technical Leaders Training Program for Major Disciplines, No. 20243BCE51001.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chuan Xie, MD, Chief Doctor, Teacher, Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Nanchang 330006, Jiangxi Province, China. xcsghhz@ncu.edu.cn
Received: August 18, 2024 Revised: October 10, 2024 Accepted: October 28, 2024 Published online: December 7, 2024 Processing time: 86 Days and 17 Hours
Core Tip
Core Tip: Rectal neuroendocrine tumours are rare, and these patients generally have a favourable prognosis; however, the presence of high-risk factors can significantly reduce patient survival. The development of predictive models such as the global alliance for trade in services score is crucial for identifying high-risk patients and guiding precise treatment strategies. However, prognostic models capable of conducting comprehensive and rigorous sample size calculations along with multicentre external validation prior to model construction remain somewhat less common. In future research, close collaboration with experts in medical statistics is imperative, with the aim of balancing clinical utility and predictive accuracy throughout the model development and optimization processes to more effectively guide stratified management of patients with rectal neuroendocrine tumours.
